{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T14:01:11Z","timestamp":1790776871239,"version":"4.1.0"},"update-to":[{"DOI":"10.1371\/journal.ppat.1009009","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2020,11,5]],"date-time":"2020-11-05T00:00:00Z","timestamp":1604534400000}}],"reference-count":78,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2020,10,26]],"date-time":"2020-10-26T00:00:00Z","timestamp":1603670400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R56AI130044"],"award-info":[{"award-number":["R56AI130044"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["R21AI146388"],"award-info":[{"award-number":["R21AI146388"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100008335","name":"Arizona Biomedical Research Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008335","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plospathogens.org"],"crossmark-restriction":false},"short-container-title":["PLoS Pathog"],"abstract":"<jats:p>\n                    A key difference that distinguishes viral infections from protein immunizations is the recognition of viral nucleic acids by cytosolic pattern recognition receptors (PRRs). Insights into the functions of cytosolic PRRs such as the RNA-sensing Rig-I-like receptors (RLRs) in the instruction of adaptive immunity are therefore critical to understand protective immunity to infections. West Nile virus (WNV) infection of mice deficent of RLR-signaling adaptor MAVS results in a defective adaptive immune response. While this finding suggests a role for RLRs in the instruction of adaptive immunity to WNV, it is difficult to interpret due to the high WNV viremia, associated exessive antigen loads, and pathology in the absence of a MAVS-dependent innate immune response. To overcome these limitations, we have infected MAVS-deficient (MAVS\n                    <jats:sup>KO<\/jats:sup>\n                    ) mice with a single-round-of-infection mutant of West Nile virus. We show that MAVS\n                    <jats:sup>KO<\/jats:sup>\n                    mice failed to produce an effective neutralizing antibody response to WNV despite normal antibody titers against the viral WNV-E protein. This defect occurred independently of antigen loads or overt pathology. The specificity of the antibody response in infected MAVS\n                    <jats:sup>KO<\/jats:sup>\n                    mice remained unchanged and was still dominated by antibodies that bound the neutralizing lateral ridge (LR) epitope in the DIII domain of WNV-E. Instead, MAVS\n                    <jats:sup>KO<\/jats:sup>\n                    mice produced IgM antibodies, the dominant isotype controlling primary WNV infection, with lower affinity for the DIII domain. Our findings suggest that RLR-dependent signals are important for the quality of the humoral immune response to WNV.\n                  <\/jats:p>","DOI":"10.1371\/journal.ppat.1009009","type":"journal-article","created":{"date-parts":[[2020,10,26]],"date-time":"2020-10-26T14:50:13Z","timestamp":1603723813000},"page":"e1009009","update-policy":"https:\/\/doi.org\/10.1371\/journal.ppat.corrections_policy","source":"Crossref","is-referenced-by-count":4,"title":["MAVS regulates the quality of the antibody response to West-Nile Virus"],"prefix":"10.1371","volume":"16","author":[{"given":"Marvin","family":"O\u2019Ketch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4601-9201","authenticated-orcid":true,"given":"Spencer","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7947-6436","authenticated-orcid":true,"given":"Cameron","family":"Larson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7745-0179","authenticated-orcid":true,"given":"Jennifer L.","family":"Uhrlaub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7837-2881","authenticated-orcid":true,"given":"Rachel","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7103-2112","authenticated-orcid":true,"given":"Brenna","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neha R.","family":"Deshpande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7585-0745","authenticated-orcid":true,"given":"Dominik","family":"Schenten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2020,10,26]]},"reference":[{"key":"ppat.1009009.ref001","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/B978-0-12-387664-5.00003-0","article-title":"The control of adaptive immune responses by the innate immune system","volume":"109","author":"D Schenten","year":"2011","journal-title":"Adv Immunol"},{"key":"ppat.1009009.ref002","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/ni.3123","article-title":"Control of adaptive immunity by the innate immune system","volume":"16","author":"A Iwasaki","year":"2015","journal-title":"Nat Immunol"},{"key":"ppat.1009009.ref003","article-title":"Beyond antigens and adjuvants: Formulating future vaccines","author":"TJ Moyer","year":"2016","journal-title":"Journal of Clinical Investigation"},{"key":"ppat.1009009.ref004","article-title":"Innate sensors that regulate vaccine responses","author":"P Georg","year":"2019","journal-title":"Current Opinion in Immunology"},{"key":"ppat.1009009.ref005","article-title":"Immunity to viruses: Learning from successful human vaccines","author":"B Pulendran","year":"2013","journal-title":"Immunol Rev"},{"key":"ppat.1009009.ref006","article-title":"Yellow fever vaccine YF-17D activates multiple dendritic cell subsets via TLR2, 7, 8, and 9 to stimulate polyvalent immunity.","author":"T Querec","year":"2006","journal-title":"J Exp Med"},{"key":"ppat.1009009.ref007","article-title":"Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans","author":"TD Querec","year":"2009","journal-title":"Nat Immunol"},{"key":"ppat.1009009.ref008","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/nature10072","article-title":"Detection of prokaryotic mRNA signifies microbial viability and promotes immunity","volume":"474","author":"LE Sander","year":"2011","journal-title":"Nature"},{"key":"ppat.1009009.ref009","article-title":"Sensing Microbial Viability through Bacterial RNA Augments T Follicular Helper Cell and Antibody Responses","author":"G Barbet","year":"2018","journal-title":"Immunity"},{"key":"ppat.1009009.ref010","article-title":"Recognition of microbial viability via TLR8 drives T FH cell differentiation and vaccine responses","author":"M Ugolini","year":"2018","journal-title":"Nat Immunol"},{"key":"ppat.1009009.ref011","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/ni.2039","article-title":"Immunological mechanisms of vaccination","volume":"12","author":"B Pulendran","year":"2011","journal-title":"Nat Immunol"},{"key":"ppat.1009009.ref012","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.vaccine.2012.10.096","article-title":"T cell vaccinology: exploring the known unknowns","volume":"31","author":"MA Burchill","year":"2013","journal-title":"Vaccine"},{"key":"ppat.1009009.ref013","article-title":"Vaccine adjuvants: Putting innate immunity to work","author":"RL Coffman","year":"2010","journal-title":"Immunity"},{"key":"ppat.1009009.ref014","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/B978-0-12-410524-9.00004-9","article-title":"Intracellular pathogen detection by RIG-I-like receptors","volume":"117","author":"E Dixit","year":"2013","journal-title":"Adv Immunol"},{"key":"ppat.1009009.ref015","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.coviro.2015.01.004","article-title":"RIG-I-like receptor regulation in virus infection and immunity.","volume":"12","author":"YK Chan","year":"2015","journal-title":"Curr Opin Virol."},{"key":"ppat.1009009.ref016","doi-asserted-by":"crossref","first-page":"194","DOI":"10.3109\/10409238.2011.630974","article-title":"Activation of RIG-I-like receptor signal transduction","volume":"47","author":"AM Bruns","year":"2012","journal-title":"Crit Rev Biochem Mol Biol"},{"key":"ppat.1009009.ref017","doi-asserted-by":"crossref","first-page":"e1000757","DOI":"10.1371\/journal.ppat.1000757","article-title":"IPS-1 is essential for the control of West Nile virus infection and immunity.","volume":"6","author":"MS Suthar","year":"2010","journal-title":"PLoS Pathog."},{"key":"ppat.1009009.ref018","doi-asserted-by":"crossref","first-page":"40720","DOI":"10.1038\/srep40720","article-title":"Extrinsic MAVS signaling is critical for Treg maintenance of Foxp3 expression following acute flavivirus infection.","volume":"7","author":"A Da Costa","year":"2017","journal-title":"Sci Rep."},{"key":"ppat.1009009.ref019","first-page":"91","article-title":"MAVS Is Essential for Primary CD4+ T Cell Immunity but Not for Recall T Cell Responses following an Attenuated West Nile Virus Infection","author":"H Luo","year":"2017","journal-title":"J Virol"},{"key":"ppat.1009009.ref020","doi-asserted-by":"crossref","first-page":"5550","DOI":"10.1016\/j.vaccine.2009.07.016","article-title":"RepliVAX WN, a single-cycle flavivirus vaccine to prevent West Nile disease, elicits durable protective immunity in hamsters","volume":"27","author":"DG Widman","year":"2009","journal-title":"Vaccine"},{"key":"ppat.1009009.ref021","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1016\/j.vaccine.2008.03.009","article-title":"Construction and characterization of a second-generation pseudoinfectious West Nile virus vaccine propagated using a new cultivation system","volume":"26","author":"DG Widman","year":"2008","journal-title":"Vaccine"},{"key":"ppat.1009009.ref022","article-title":"Immunogenicity of RepliVAX WN, a novel single-cycle West Nile virus vaccine","author":"MH Nelson","year":"2010","journal-title":"Vaccine"},{"key":"ppat.1009009.ref023","article-title":"A Critical Role for Induced IgM in the Protection against West Nile Virus Infection","author":"MS Diamond","year":"2003","journal-title":"J Exp Med"},{"key":"ppat.1009009.ref024","article-title":"CD4+ T-Cell Responses Are Required for Clearance of West Nile Virus from the Central Nervous System","author":"EM Sitati","year":"2006","journal-title":"J Virol"},{"key":"ppat.1009009.ref025","doi-asserted-by":"crossref","first-page":"E2058","DOI":"10.1073\/pnas.1716937115","article-title":"STING-dependent translation inhibition restricts RNA virus replication","volume":"115","author":"KM Franz","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ppat.1009009.ref026","article-title":"Sequential changes in the relative affinity of antibodies synthesized during the immune response","author":"LA Steiner","year":"1967","journal-title":"J Exp Med"},{"key":"ppat.1009009.ref027","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1021\/bi00895a027","article-title":"Variations in Affinities of Antibodies during the Immune Response","volume":"3","author":"HN Eisen","year":"1964","journal-title":"Biochemistry"},{"key":"ppat.1009009.ref028","article-title":"Germinal center dynamics revealed by multiphoton microscopy with a photoactivatable fluorescent reporter","author":"GD Victora","year":"2010","journal-title":"Cell"},{"key":"ppat.1009009.ref029","first-page":"78","article-title":"Toll-like receptor-induced IL-1 releases na\u00efve CD4+ T cells from regulatory T cell-mediated suppression in vivo","volume":"40","author":"D Schenten","year":"2014","journal-title":"Immunity"},{"key":"ppat.1009009.ref030","first-page":"e01949","article-title":"T cell-intrinsic role of IL-6 signaling in primary and memory responses.","volume":"3","author":"SA Nish","year":"2014","journal-title":"Elife (Cambridge)."},{"key":"ppat.1009009.ref031","doi-asserted-by":"crossref","first-page":"13097","DOI":"10.1128\/JVI.76.24.13097-13100.2002","article-title":"Identification of neutralizing epitopes within structural domain III of the West Nile virus envelope protein","volume":"76","author":"DW Beasley","year":"2002","journal-title":"J Virol"},{"key":"ppat.1009009.ref032","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/nm1240","article-title":"Development of a humanized monoclonal antibody with therapeutic potential against West Nile virus","volume":"11","author":"T Oliphant","year":"2005","journal-title":"Nat Med"},{"key":"ppat.1009009.ref033","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/nature03956","article-title":"Structural basis of West Nile virus neutralization by a therapeutic antibody","volume":"437","author":"GE Nybakken","year":"2005","journal-title":"Nature"},{"key":"ppat.1009009.ref034","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1084\/jem.20110740","article-title":"Memory B cells, but not long-lived plasma cells, possess antigen specificities for viral escape mutants","volume":"208","author":"WE Purtha","year":"2011","journal-title":"J Exp Med"},{"key":"ppat.1009009.ref035","article-title":"B Cells and Antibody Play Critical Roles in the Immediate Defense of Disseminated Infection by West Nile Encephalitis Virus","author":"MS Diamond","year":"2003","journal-title":"J Virol"},{"key":"ppat.1009009.ref036","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.3390\/v6031015","article-title":"B cell response and mechanisms of antibody protection to West Nile virus","volume":"6","author":"SK Austin","year":"2014","journal-title":"Viruses"},{"key":"ppat.1009009.ref037","doi-asserted-by":"crossref","first-page":"7098","DOI":"10.1128\/JVI.00707-16","article-title":"MAVS Expressed by Hematopoietic Cells Is Critical for Control of West Nile Virus Infection and Pathogenesis","volume":"90","author":"J Zhao","year":"2016","journal-title":"J Virol"},{"key":"ppat.1009009.ref038","article-title":"CD40-CD40 Ligand Interactions Promote Trafficking of CD8+ T Cells into the Brain and Protection against West Nile Virus Encephalitis","author":"E Sitati","year":"2007","journal-title":"J Virol"},{"key":"ppat.1009009.ref039","article-title":"TLR3- and MyD88-Dependent Signaling Differentially Influences the Development of West Nile Virus-Specific B Cell Responses in Mice following Immunization with RepliVAX WN, a Single-Cycle Flavivirus Vaccine Candidate","author":"J Xia","year":"2013","journal-title":"J Virol"},{"key":"ppat.1009009.ref040","article-title":"The structural immunology of antibody protection against West Nile virus","author":"MS Diamond","year":"2008","journal-title":"Immunological Reviews"},{"key":"ppat.1009009.ref041","article-title":"A detailed mutagenesis study of flavivirus cross-reactive epitopes using west Nile virus-like particles","author":"WD Crill","year":"2007","journal-title":"J Gen Virol"},{"key":"ppat.1009009.ref042","article-title":"Localization and Characterization of Flavivirus Envelope Glycoprotein Cross-Reactive Epitopes","author":"WD Crill","year":"2004","journal-title":"J Virol"},{"key":"ppat.1009009.ref043","article-title":"The DE loop of the domain III of the envelope protein appears to be associated with West Nile virus neutralization","author":"KS Choi","year":"2007","journal-title":"Virus Res"},{"key":"ppat.1009009.ref044","article-title":"Characterization of neutralizing antibodies to West Nile virus","author":"MD S\u00e1nchez","year":"2005","journal-title":"Virology"},{"key":"ppat.1009009.ref045","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.chom.2007.03.002","article-title":"The stoichiometry of antibody-mediated neutralization and enhancement of West Nile virus infection","volume":"1","author":"TC Pierson","year":"2007","journal-title":"Cell Host Microbe"},{"key":"ppat.1009009.ref046","article-title":"Antibody-mediated enhancement of Flavivirus replication in macrophage-Like cell lines [15]","author":"JSM Peiris","year":"1979","journal-title":"Nature"},{"key":"ppat.1009009.ref047","article-title":"Monoclonal anti-Fc receptor IgG blocks antibody enhancement of viral replication in macrophages","author":"JSM Peiris","year":"1981","journal-title":"Nature"},{"key":"ppat.1009009.ref048","article-title":"Differential Enhancement of Dengue Virus Immune Complex Infectivity Mediated by Signaling-Competent and Signaling-Incompetent Human Fc\u03b3RIA (CD64) or Fc\u03b3RIIA (CD32).","author":"WWSI Rodrigo","year":"2006","journal-title":"J Virol"},{"key":"ppat.1009009.ref049","article-title":"Enhancement of Zika virus pathogenesis by preexisting antiflavivirus immunity","author":"V. Bardina S","year":"2017","journal-title":"Science (80-)."},{"key":"ppat.1009009.ref050","article-title":"Pathogenesis of dengue: Challenges to molecular biology","author":"SB Halstead","year":"1988","journal-title":"Science (80-)."},{"key":"ppat.1009009.ref051","article-title":"Studies on the pathogenesis of dengue infection in monkeys. I. clinical laboratory responses to primary infection","author":"SB Halstead","year":"1973","journal-title":"J Infect Dis"},{"key":"ppat.1009009.ref052","article-title":"In vivo enhancement of dengue virus infection in rhesus monkeys by passively transferred antibody","author":"SB Halstead","year":"1979","journal-title":"J Infect Dis"},{"key":"ppat.1009009.ref053","article-title":"IgG antibodies to dengue enhanced for Fc\u03b3RIIIA binding determine disease severity","author":"TT Wang","year":"2017","journal-title":"Science"},{"key":"ppat.1009009.ref054","article-title":"Antibody-dependent enhancement of severe dengue disease in humans","author":"LC Katzelnick","year":"2017","journal-title":"Science (80-)."},{"key":"ppat.1009009.ref055","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.chom.2009.09.003","article-title":"Complement protein C1q reduces the stoichiometric threshold for antibody-mediated neutralization of West Nile virus.","volume":"6","author":"E Mehlhop","year":"2009","journal-title":"Cell Host Microbe."},{"key":"ppat.1009009.ref056","article-title":"Infection-Enhancing and -Neutralizing Activities of Mouse Monoclonal Antibodies against Dengue Type 2 and 4 Viruses Are Controlled by Complement Levels","author":"A Yamanaka","year":"2008","journal-title":"J Virol"},{"key":"ppat.1009009.ref057","article-title":"Complement Protein C1q Inhibits Antibody-Dependent Enhancement of Flavivirus Infection in an IgG Subclass-Specific Manner.","author":"E Mehlhop","year":"2007","journal-title":"Cell Host Microbe."},{"key":"ppat.1009009.ref058","doi-asserted-by":"crossref","first-page":"13350","DOI":"10.1128\/JVI.79.21.13350-13361.2005","article-title":"Alpha\/beta interferon protects against lethal West Nile virus infection by restricting cellular tropism and enhancing neuronal survival","volume":"79","author":"MA Samuel","year":"2005","journal-title":"J Virol"},{"key":"ppat.1009009.ref059","article-title":"Dendritic cell-associated MAVS is required to control West Nile virus replication and ensuing humoral immune responses.","author":"K Roe","year":"2019","journal-title":"PLoS One."},{"key":"ppat.1009009.ref060","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1093\/intimm\/14.4.411","article-title":"IFN-alpha\/beta enhances BCR-dependent B cell responses","volume":"14","author":"D Braun","year":"2002","journal-title":"Int Immunol"},{"key":"ppat.1009009.ref061","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1002\/eji.200635993","article-title":"Early type I interferon-mediated signals on B cells specifically enhance antiviral humoral responses","volume":"36","author":"K Fink","year":"2006","journal-title":"Eur J Immunol"},{"key":"ppat.1009009.ref062","doi-asserted-by":"crossref","first-page":"4343","DOI":"10.4049\/jimmunol.176.7.4343","article-title":"Type I IFN receptor signals directly stimulate local B cells early following influenza virus infection","volume":"176","author":"ES Coro","year":"2006","journal-title":"J Immunol"},{"key":"ppat.1009009.ref063","article-title":"Inhibition of Alpha\/Beta Interferon Signaling by the NS4B Protein of Flaviviruses","author":"JL Munoz-Jordan","year":"2005","journal-title":"J Virol"},{"key":"ppat.1009009.ref064","article-title":"Infectious Clones of Novel Lineage 1 and Lineage 2 West Nile Virus Strains WNV-TX02 and","author":"MS Suthar","year":"2012","journal-title":"WNV-Madagascar. J Virol"},{"key":"ppat.1009009.ref065","article-title":"Immune responses to an attenuated West Nile virus NS4B-P38G mutant strain","author":"T Welte","year":"2011","journal-title":"Vaccine"},{"key":"ppat.1009009.ref066","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.immuni.2013.10.023","article-title":"Signaling through the adaptor molecule MyD88 in CD4+ T cells is required to overcome suppression by regulatory T cells","volume":"40","author":"D Schenten","year":"2014","journal-title":"Immunity"},{"key":"ppat.1009009.ref067","article-title":"T fr cells lack IL-2R\u03b1 but express decoy IL-1R2 and IL-1Ra and suppress the IL-1\u2013dependent activation of T fh cells.","author":"P-GG Ritvo","year":"2017","journal-title":"Sci Immunol."},{"key":"ppat.1009009.ref068","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/nature13300","article-title":"Clonal selection in the germinal centre by regulated proliferation and hypermutation","volume":"509","author":"AD Gitlin","year":"2014","journal-title":"Nature"},{"key":"ppat.1009009.ref069","article-title":"A dynamic T cell-limited checkpoint regulates affinity-dependent B cell entry into the germinal center","author":"TA Schwickert","year":"2011","journal-title":"J Exp Med"},{"key":"ppat.1009009.ref070","article-title":"Activation of the RIG-I Pathway during Influenza Vaccination Enhances the Germinal Center Reaction, Promotes T Follicular Helper Cell Induction, and Provides a Dose-Sparing Effect and Protective Immunity","author":"RR Kulkarni","year":"2014","journal-title":"J Virol"},{"key":"ppat.1009009.ref071","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/ni1162","article-title":"Inflammatory mediators are insufficient for full dendritic cell activation and promote expansion of CD4+ T cell populations lacking helper function","volume":"6","author":"R Sporri","year":"2005","journal-title":"Nat Immunol"},{"key":"ppat.1009009.ref072","doi-asserted-by":"crossref","first-page":"10338","DOI":"10.1073\/pnas.96.18.10338","article-title":"Mice lacking all conventional MHC class II genes","volume":"96","author":"L Madsen","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ppat.1009009.ref073","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/360225a0","article-title":"Mutations in T-cell antigen receptor genes alpha and beta block thymocyte development at different stages","volume":"360","author":"P Mombaerts","year":"1992","journal-title":"Nature"},{"key":"ppat.1009009.ref074","article-title":"IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction","author":"T Kawai","year":"2005","journal-title":"Nat Immunol"},{"key":"ppat.1009009.ref075","doi-asserted-by":"crossref","first-page":"3882","DOI":"10.4049\/jimmunol.1002799","article-title":"Repeated in vivo stimulation of T and B cell responses in old mice generates protective immunity against lethal West Nile virus encephalitis","volume":"186","author":"JL Uhrlaub","year":"2011","journal-title":"J Immunol"},{"key":"ppat.1009009.ref076","first-page":"e05949","article-title":"Self-recognition drives the preferential accumulation of promiscuous CD4(+) T-cells in aged mice.","volume":"4","author":"NR Deshpande","year":"2015","journal-title":"Elife (Cambridge)."},{"key":"ppat.1009009.ref077","doi-asserted-by":"crossref","first-page":"11828","DOI":"10.1128\/JVI.00643-07","article-title":"Induction of epitope-specific neutralizing antibodies against West Nile virus","volume":"81","author":"T Oliphant","year":"2007","journal-title":"J Virol"},{"key":"ppat.1009009.ref078","article-title":"Mouse and human monoclonal antibodies protect against infection by multiple genotypes of japanese encephalitis virus.","author":"E Fernandez","year":"2018","journal-title":"MBio"}],"updated-by":[{"DOI":"10.1371\/journal.ppat.1009009","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2020,11,5]],"date-time":"2020-11-05T00:00:00Z","timestamp":1604534400000}}],"container-title":["PLOS Pathogens"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.ppat.1009009","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,5]],"date-time":"2020-11-05T13:59:02Z","timestamp":1604584742000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.ppat.1009009"}},"subtitle":[],"editor":[{"given":"Sonja","family":"Best","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2020,10,26]]},"references-count":78,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2020,10,26]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.ppat.1009009","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2019.12.15.875906","asserted-by":"object"}]},"ISSN":["1553-7374"],"issn-type":[{"value":"1553-7374","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,26]]}}}